Guggenheim Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.2M | Buy |
|
|||||
|
2025
Q1 | $59.5M | Sell |
|
|||||
|
2024
Q4 | $59.8M | Sell |
|
|||||
|
2024
Q3 | $57.1M | Sell |
|
|||||
|
2024
Q2 | $53.4M | Buy |
|
|||||
|
2024
Q1 | $51M | Sell |
|
|||||
|
2023
Q4 | $61.6M | Sell |
|
|||||
|
2023
Q3 | $57.5M | Sell |
|
|||||
|
2023
Q2 | $61M | Buy |
|
|||||
|
2023
Q1 | $64M | Sell |
|
|||||
|
2022
Q4 | $69M | Sell |
|
|||||
|
2022
Q3 | $52.3M | Sell |
|
|||||
|
2022
Q2 | $54.7M | Sell |
|
|||||
|
2022
Q1 | $53.5M | Sell |
|
|||||
|
2021
Q4 | $66.1M | Buy |
|
|||||
|
2021
Q3 | $57M | Sell |
|
|||||
|
2021
Q2 | $57.3M | Buy |
|
|||||
|
2021
Q1 | $51.6M | Sell |
|
|||||
|
2020
Q4 | $47.2M | Buy |
|
|||||
|
2020
Q3 | $50.3M | Sell |
|
|||||
|
2020
Q2 | $65.6M | Buy |
|
|||||
|
2020
Q1 | $57.5M | Sell |
|
|||||
|
2019
Q4 | $59.6M | Buy |
|
|||||
|
2019
Q3 | $53.2M | Buy |
|
|||||
|
2019
Q2 | $55.3M | Sell |
|
|||||
|
2019
Q1 | $54.9M | Buy |
|
|||||
|
2018
Q4 | $44.9M | Sell |
|
|||||
|
2018
Q3 | $56.8M | Sell |
|
|||||
|
2018
Q2 | $55.6M | Sell |
|
|||||
|
2018
Q1 | $106M | Sell |
|
|||||
|
2017
Q4 | $107M | Buy |
|
|||||
|
2017
Q3 | $121M | Sell |
|
|||||
|
2017
Q2 | $124M | Buy |
|
|||||
|
2017
Q1 | $103M | Sell |
|
|||||
|
2016
Q4 | $111M | Sell |
|
|||||
|
2016
Q3 | $127M | Buy |
|
|||||
|
2016
Q2 | $127M | Sell |
|
|||||
|
2016
Q1 | $141M | Sell |
|
|||||
|
2015
Q4 | $182M | Sell |
|
|||||
|
2015
Q3 | $189M | Sell |
|
|||||
|
2015
Q2 | $247M | Sell |
|
|||||
|
2015
Q1 | $220M | Buy |
|
|||||
|
2014
Q4 | $172M | Sell |
|
|||||
|
2014
Q3 | $197M | Sell |
|
|||||
|
2014
Q2 | $161M | Sell |
|
|||||
|
2014
Q1 | $141M | Buy |
|
|||||
|
2013
Q4 | $122M | Sell |
|
|||||
|
2013
Q3 | $105M | Buy |
|
|||||
|
2013
Q2 | $73.9M | Buy |
|